1. Asghari Ghadi, Mehdi. 2011.Study the effectiveness of the vaccine FdRev.1 in sheep Semnan province in 2011. 4 th National Iranian congress of Brucellosis, Trhran. Iran. 13-15 December 2011. pp 8-9.
2. Aldomy, F., Alkhawaldeh, M. and Younis, I.B., 2009. Immune responses of goats (Shami breed) to vaccination with a full, reduced and conjunctival dose of brucevac (Brucella melitensis Rev. 1) vaccine. Pak. Vet. J, 29, pp.149-153.
3. Cutler, S.J., Whatmore, A.M. and Commander, N.J., 2005. Brucellosis–new aspects of an old disease. Journal of applied microbiology, 98(6), pp.1270-1281.
4. Dostdari, S. Hassannia, E. khafri, A. Anahita, E. Alamiyan,S. Bagherinejad, R. Baggeri, S. 2015. Stability Study of Rev.1 Reduc dose Brucellosis Vaccine Produced by Razi Institute in Iran. 19th Iranian Veterinary Congress. Tehran. Iran. 25-27 April 2015. PP 1.
5. Hasannia, E., Soleimani, S., Alamian, S., Behrozikhah, A., Emadi, A. and Dostdari, S., 2015. Stability study of IRIBA brucellosis full-dose and reduced-dose vaccine produced by Razi Institute in Iran. Archives of Razi Institute, 70(1), pp.37-44
6. Jones, L.M., Entessar, F. and Ardalan, A.1964.. Comparison of living vaccine in producing immunity against natural Brucella melitensis infection in sheeps and goats in Iran. Computational and Mathematical Organization Theory Vol.74 ,No 1.
7. Hirsh, D.C. and Zee, Y.C., 1999. Veterinary Microbiology. USA, Black well science. Pp. 115-249
8. Khorasgani, R., M. Esmaeili, M.R. Pourkarim, A.R. Mankhian and T.Z. Salehi, 2008. Antibrucella antibodies in blood donors in Boushehr. Iran Comparative Clinical Pathol., 17: 267-269
9. Lapaque, N., Moriyon, I., Moreno, E. and Gorvel, J.P., 2005. Brucella lipopolysaccharide acts as a virulence factor. Current opinion in microbiology, 8(1), pp.60-66.
10. Simmons, M.M., Stack, M.J., Konold, T. and Webster, K., 2009. OIE manual of diagnostic tests and vaccines for terrestrial animals.
11. Radostits, O.M., Gay, C.C., Hinchcliff, K.W. and Constable, P.D., 2007. Diseases associated with helminth parasites. Veterinary Medicine: A textbook of the diseases of cattle, horses, sheep, pigs, and goats. 10th ed. Saunders Elsevier, Philadelphia, pp.1541-1563.
12. Ragan VE. 2002. The animal and plant health inspection service (APHIS) brucellosis eradication program in the United States. Vet Microbiol.; 90(1-4): 11-8.
13. Shayestehpour, M., Shafyi, A., Taqavian, M., Esna-ashari, F., Mohammadi, A. and Shahbazi, R., 2012. A study of the thermal stability of measles vaccine produced by AIK-C strain. Arak Medical University Journal, 15(4), pp.26-33.
14. Soleimani, S., 2016. Stability Study of Measles AIK-C Strain, Mumps RS-12 Strain and Rubella Takahashi Strain in MMR Vaccine. Archives of Razi Institute, 71(1), pp.21-28.
15. Geneva, J.F.W., 1986. Expert committee on brucellosis (sixth report). Geneva: World Health Organization.
16. Joint, F.A.O., 1970. WHO Expert Committee on Brucellosis (1971). Fifth report, pp.71-72.
17. Cosivi, O. and Corbel, M.J., 1998. WHO consultation on the development of new/improved brucellosis vaccines. Biologicals, 26(4), pp.361-363.
18. World Health Organization, 1977. Requirements for Brucella melitensis strain Rev 1 vaccine (live for veterinary use). WHO Tech. Rep. Ser, 610, pp.85-97.
19. World Health Organization, 1997. Fact sheet N173. World Health Organization, Geneva, Switzerland.
20. Zowghi, E. and Ebadi, A., 1985. Serological investigations on brucellosis in cattle, sheep and goats in Iran. Revue Scientifique et Technique de l'OIE (France).
21. OIE Manual of diagnostic tests and vaccines for terrestrial animals (2016), 7th edn, world organization for animal health. Chapter 2.4.3.
22. The Offical compendia of standard, U.S. Pharmacopoeia, the standard of quality (2012). USB 35, NF30- Water Determination(921).